Allison Widlitz

2.5k total citations
25 papers, 1.8k citations indexed

About

Allison Widlitz is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Allison Widlitz has authored 25 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 15 papers in Cardiology and Cardiovascular Medicine and 5 papers in Genetics. Recurrent topics in Allison Widlitz's work include Pulmonary Hypertension Research and Treatments (22 papers), Cardiovascular Issues in Pregnancy (13 papers) and Vascular Anomalies and Treatments (5 papers). Allison Widlitz is often cited by papers focused on Pulmonary Hypertension Research and Treatments (22 papers), Cardiovascular Issues in Pregnancy (13 papers) and Vascular Anomalies and Treatments (5 papers). Allison Widlitz collaborates with scholars based in United States, United Kingdom and Switzerland. Allison Widlitz's co-authors include Robyn J. Barst, Erika B. Rosenzweig, Vallerie V. McLaughlin, Evelyn M. Horn, Mardi Gomberg‐Maitland, Victor F. Tapson, Abigail Krichman, Raymond L. Benza, Diane Kerstein and Delphine Yung and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Allison Widlitz

24 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allison Widlitz United States 15 1.7k 1.1k 398 315 213 25 1.8k
Christiana Blair United States 19 1.2k 0.7× 865 0.8× 248 0.6× 135 0.4× 154 0.7× 41 1.6k
Jean-Luc Vachiéry Belgium 11 1.4k 0.8× 981 0.9× 123 0.3× 177 0.6× 57 0.3× 20 1.7k
Mitja Jevnikar France 17 1.3k 0.8× 901 0.8× 235 0.6× 96 0.3× 126 0.6× 54 1.4k
Mona Selej United States 14 1.1k 0.7× 739 0.6× 140 0.4× 94 0.3× 134 0.6× 35 1.2k
Delphine Natali France 9 839 0.5× 538 0.5× 203 0.5× 59 0.2× 99 0.5× 23 942
Hilary M. DuBrock United States 16 752 0.5× 472 0.4× 127 0.3× 147 0.5× 254 1.2× 81 1.1k
Marcus T.R. Roofthooft Netherlands 20 1.1k 0.7× 703 0.6× 217 0.5× 555 1.8× 56 0.3× 33 1.3k
Nilda Espínola‐Zavaleta Mexico 18 645 0.4× 810 0.7× 78 0.2× 291 0.9× 45 0.2× 182 1.3k
Laurent Godinas Belgium 18 835 0.5× 462 0.4× 108 0.3× 128 0.4× 43 0.2× 68 1.1k
Emanuele Romeo Italy 22 1.0k 0.6× 982 0.9× 70 0.2× 345 1.1× 51 0.2× 64 1.4k

Countries citing papers authored by Allison Widlitz

Since Specialization
Citations

This map shows the geographic impact of Allison Widlitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison Widlitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison Widlitz more than expected).

Fields of papers citing papers by Allison Widlitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison Widlitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison Widlitz. The network helps show where Allison Widlitz may publish in the future.

Co-authorship network of co-authors of Allison Widlitz

This figure shows the co-authorship network connecting the top 25 collaborators of Allison Widlitz. A scholar is included among the top collaborators of Allison Widlitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison Widlitz. Allison Widlitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Widlitz, Allison, et al.. (2007). Practical Aspects of Continuous Intravenous Treprostinil Therapy. Critical Care Nurse. 27(2). 41–50. 11 indexed citations
2.
Rosenzweig, Erika B., Allison Widlitz, Aimee Doran, et al.. (2006). Reply. Journal of the American College of Cardiology. 47(9). 1915–1915. 1 indexed citations
3.
Tapson, Victor F., Mardi Gomberg‐Maitland, Vallerie V. McLaughlin, et al.. (2006). Safety and Efficacy of IV Treprostinil for Pulmonary Arterial Hypertension. CHEST Journal. 129(3). 683–688. 220 indexed citations
4.
Kawut, Steven M., Evelyn M. Horn, Ketevan Berekashvili, et al.. (2006). Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension. Pulmonary Pharmacology & Therapeutics. 19(5). 370–374. 59 indexed citations
5.
Tapson, Victor F., Vallerie V. McLaughlin, Mardi Gomberg‐Maitland, et al.. (2006). Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension. The Journal of Vascular Access. 7(3). 112–117. 16 indexed citations
6.
Gomberg‐Maitland, Mardi, Victor F. Tapson, Raymond L. Benza, et al.. (2005). Transition from Intravenous Epoprostenol to Intravenous Treprostinil in Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 172(12). 1586–1589. 174 indexed citations
7.
Rosenzweig, Erika B., D. Dunbar Ivy, Allison Widlitz, et al.. (2005). Effects of Long-Term Bosentan in Children With Pulmonary Arterial Hypertension. Journal of the American College of Cardiology. 46(4). 697–704. 191 indexed citations
8.
Roberts, Kari E., Robyn J. Barst, Jude J. McElroy, et al.. (2005). Bone Morphogenetic Protein Receptor 2 Mutations in Adults and Children With Idiopathic Pulmonary Arterial Hypertension. CHEST Journal. 128(6). 618S–618S. 14 indexed citations
9.
Kawut, Steven M., Evelyn M. Horn, Ketevan Berekashvili, et al.. (2005). New predictors of outcome in idiopathic pulmonary arterial hypertension. The American Journal of Cardiology. 95(2). 199–203. 191 indexed citations
10.
Kawut, Steven M., Evelyn M. Horn, Ketevan Berekashvili, et al.. (2005). von Willebrand Factor Independently Predicts Long-term Survival in Patients With Pulmonary Arterial Hypertension. CHEST Journal. 128(4). 2355–2362. 59 indexed citations
11.
McLaughlin, Vallerie V., Robyn J. Barst, Mardi Gomberg‐Maitland, et al.. (2005). ONE YEAR EXPERIENCE WITH INTRAVENOUS TREPROSTINIL IN PULMONARY ARTERIAL HYPERTENSION (PAH) PATIENTS. CHEST Journal. 128(4). 160S–160S. 3 indexed citations
12.
Widlitz, Allison, Robyn J. Barst, & Evelyn M. Horn. (2005). Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertension. Expert Review of Cardiovascular Therapy. 3(6). 985–991. 17 indexed citations
13.
Roberts, Kari E., Jude J. McElroy, Wai Peng Wong, et al.. (2004). BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease. European Respiratory Journal. 24(3). 371–374. 180 indexed citations
14.
Oudiz, Ronald J., et al.. (2004). Micrococcus-Associated Central Venous Catheter Infection in Patients With Pulmonary Arterial Hypertension. CHEST Journal. 126(1). 90–94. 88 indexed citations
15.
Rosenzweig, Erika B., Allison Widlitz, & Robyn J. Barst. (2004). Pulmonary arterial hypertension in children. Pediatric Pulmonology. 38(1). 2–22. 85 indexed citations
16.
Sobol, Irina, Robyn J. Barst, Kenneth J. Nichols, et al.. (2004). Correlation between right ventricular ejection fraction obtained with gated equilibrium blood pool spect imaging and right atrial pressure in patients with primary pulmonary hypertension. Journal of Nuclear Cardiology. 11(4). S25–S26. 1 indexed citations
17.
Yung, Delphine, Allison Widlitz, Erika B. Rosenzweig, et al.. (2004). Outcomes in Children With Idiopathic Pulmonary Arterial Hypertension. Circulation. 110(6). 660–665. 178 indexed citations
18.
Barst, Robyn J., et al.. (2003). Sitaxsentan in Pulmonary Arterial Hypertension. CHEST Journal. 123(5). 1772–1773. 1 indexed citations
19.
Widlitz, Allison & Robyn J. Barst. (2003). Pulmonary arterial hypertension in children. European Respiratory Journal. 21(1). 155–176. 122 indexed citations
20.
Barst, Robyn J., et al.. (2002). Clinical Efficacy of Sitaxsentan, an Endothelin-A Receptor Antagonist, in Patients With Pulmonary Arterial Hypertension. CHEST Journal. 121(6). 1860–1868. 171 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christiana Blair Breakdown of academic impact, for papers by Jean-Luc Vachiéry Breakdown of academic impact, for papers by Mitja Jevnikar Breakdown of academic impact, for papers by Mona Selej Breakdown of academic impact, for papers by Delphine Natali Breakdown of academic impact, for papers by Hilary M. DuBrock Breakdown of academic impact, for papers by Marcus T.R. Roofthooft Breakdown of academic impact, for papers by Nilda Espínola‐Zavaleta Breakdown of academic impact, for papers by Laurent Godinas Breakdown of academic impact, for papers by Emanuele Romeo
Rankless by CCL
2026